Market Overview

20 Biggest Mid-Day Losers For Thursday

  • Streamline Health Solutions Inc. (NASDAQ: STRM) shares tumbled 29.4 percent to $1.90 after climbing 75.82 percent on Wednesday.
  • Digirad Corporation (NASDAQ: DRAD) shares declined 26.8 percent to $2.49.
  • Intellicheck Inc (NYSE: IDN) shares dipped 19.1 percent to $2.33. Intellicheck named Bill White as Interim President and CEO amid departure of William Roof.
  • MediciNova, Inc. (NASDAQ: MNOV) shares declined 16.6 percent to $5.80.
  • Medical Transcription Billing Corp (NASDAQ: MTBC) shares fell 14.3 percent to $2.79.
  • China Internet Nationwide Fncl Srvcs Inc (NASDAQ: CIFS) shares dropped 13.6 percent to $20.05.
  • Vericel Corp (NASDAQ: VCEL) shares tumbled 12.2 percent to $5.25 as the company issued a general business update at the 2017 Cell & Gene Meeting on the Mesa. Vericel reported plans for further expansion of MACI sales force in 2018.
  • Navient Corp (NASDAQ: NAVI) fell 10 percent to $13.23 after the company announced plans to buy Earnest for $155 million in cash. Compass Point downgraded Navient from Buy to Neutral.
  • Benitec Biopharma Ltd (ADR) (NASDAQ: BNTC) shares declined 10 percent to $2.69.
  • NeoPhotonics Corp (NYSE: NPTN) dropped 9.7 percent to $5.29 after the company lowered its Q3 earnings outlook and reported the implementation of certain restructuring actions, including workforce reduction.
  • Endocyte, Inc. (NASDAQ: ECYT) shares declined 6.7 percent to $5.69 after gaining 3.74 percent on Wednesday.
  • Shopify Inc (US) (NYSE: SHOP) shares fell 6.1 percent to $97.06.
  • ImmunoGen, Inc. (NASDAQ: IMGN) shares declined 5.8 percent to $7.38. ImmunoGen disclosed a 13 million share offering of common stock.
  • Capricor Therapeutics Inc (NASDAQ: CAPR) dropped 5.3 percent to $2.96 after declining 4.88 percent on Wednesday.
  • Celgene Corporation (NASDAQ: CELG) declined 4.6 percent to $139.76. Morgan Stanley downgraded Celgene from Equal-Weight to Underweight.
  • FibroGen Inc (NASDAQ: FGEN) shares fell 4.5 percent to $57.38. Mizuho initiated coverage on FibroGen with a Neutral rating.
  • Mallinckrodt PLC (NYSE: MNK) slipped 4.3 percent to $35.74. Canaccord Genuity downgraded Mallinckrodt from Buy to Hold.
  • Globalstar, Inc. (NYSE: GSAT) fell 4.3 percent to $1.78. Globalstar reported a $125 million offering of common stock.
  • Matador Resources Co (NYSE: MTDR) slipped 3.8 percent to $26.27. Matador Resources priced offering of 8 million shares for gross proceeds of $210.8 million.
  • Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) declined 3.7 percent to $14.55. Stifel Nicolaus downgraded Momenta Pharmaceuticals from Buy to Hold.

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets Analyst Ratings Movers


Related Articles (CAPR + BNTC)

View Comments and Join the Discussion!

Latest Ratings

INTUMorgan StanleyMaintains245.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Trader Essentials
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Google's Hardware Strategy, Explained

Finding High-Quality Companies Today